Page last updated: 2024-08-24

triazoles and vicriviroc

triazoles has been researched along with vicriviroc in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	15 (55.56)	29.6817
2010's	12 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goebel, FD; Horster, S	1
Franti, M; Maddon, PJ; Murga, JD; Olson, WC; Pevear, DC	1
Temesgen, Z	1
Ahuja, SK; He, W; Ketas, TJ; Klasse, PJ; Kuhmann, SE; Moore, JP; Palmer, A; Zurita, J	1
Kuritzkes, DR	1
Alton, KB; Chowdhury, SK; Ghosal, A; Hapangama, N; Kishnani, NS; Ramanathan, R; Yuan, Y	1
Emmelkamp, JM; Rockstroh, JK	1
Lorenzen, T; Plettenberg, A; Stoehr, A; Walther, I	1
Bredeek, UF; Harbour, MJ	1
Dioszegi, M; Ji, C; Kondru, R; Mirzadegan, T; Rotstein, D; Sankuratri, S; Zhang, J	1
de la Tribonnière, X; Reynes, J; Yazdanpanah, Y	1
Arenzana-Seisdedos, F	1
Kuritzkes, DR; Moore, JP	1
Fätkenheuer, G; Kümmerle, T; Lehmann, C; Meuer, K	1
McKinnell, JA; Saag, MS	1
Henrich, TJ; Konstantinidis, I; Kuritzkes, DR; Leopold, KE; Lewine, NR; Sagar, M; Tsibris, AM	1
Banerjee, S; Grunbeck, A; Huber, T; Knepp, AM; Sakmar, TP	1
Hosoya, N; Iwamoto, A; Kawana-Tachikawa, A	1
Büchel, G; Haefeli, WE; Herzog, M; Jödicke, L; Weiss, J; Zembruski, NC	1
Dixit, NM; Mulampaka, SN	1
Berro, R; Flegler, A; Hope, TJ; Klasse, PJ; Lascano, D; Moore, JP; Nagashima, KA; Sakmar, TP; Sanders, RW	1
Berro, R; Gulick, RM; Henrich, TJ; Kuritzkes, DR; Lee, SH; Lewine, NR; Moore, JP; Rao, SS; Tsibris, AM	1
Berro, R; Gorry, PR; Jakobsen, MR; Klasse, PJ; Moore, JP; Sanders, RW	1
De La Fuente, M; Ertel, A; Jiao, X; Lisanti, MP; Pestell, RG; Pestell, TG; Velasco-Velázquez, M	1
Abi-Habib, S; Abrol, R; Berro, R; Goddard, WA; Grunbeck, A; Klasse, PJ; Lascano, D; Moore, JP; Sakmar, TP; Trzaskowski, B; Yasmeen, A	1
Guo, H; Kong, X; Liu, B; Liu, C; Wood, C	1
Asin-Milan, O; Belanger-Jasmin, G; Blackburn, J; Chamberland, A; El-Far, M; Haidara, A; Sylla, M; Tremblay, CL	1

Reviews

8 review(s) available for triazoles and vicriviroc

Article	Year
Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edge. Infection, 2006, Volume: 34, Issue:2 Topics: Benzoates; CCR5 Receptor Antagonists; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Piperazines; Pyrimidines; Spiro Compounds; Treatment Outcome; Triazoles	2006
CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature. European journal of medical research, 2007, Oct-15, Volume: 12, Issue:9 Topics: Anti-HIV Agents; Benzoates; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; Drug Interactions; Humans; Maraviroc; Piperazines; Pyrimidines; Spiro Compounds; Triazoles	2007
CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1. European journal of medical research, 2007, Oct-15, Volume: 12, Issue:9 Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; HIV Infections; HIV-1; Humans; Maraviroc; Piperazines; Pyrimidines; Triazoles	2007
CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1. European journal of medical research, 2007, Oct-15, Volume: 12, Issue:9 Topics: Adolescent; Adult; Anti-HIV Agents; Benzoates; CCR5 Receptor Antagonists; Cyclohexanes; Diketopiperazines; Female; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Piperazines; Pyrimidines; Randomized Controlled Trials as Topic; Spiro Compounds; Triazoles	2007
[Viral entry as therapeutic target. Current situation of entry inhibitors]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 11 Topics: Adult; Amides; Benzoates; CCR5 Receptor Antagonists; CD4 Antigens; Chemokines, CC; Chemokines, CXC; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Membrane Fusion; Models, Molecular; Piperazines; Pyrimidines; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, CXCR4; Spiro Compounds; Structure-Activity Relationship; Triazoles; Virus Attachment; Virus Internalization	2008
A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors. Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:2 Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Maraviroc; Mutation, Missense; Piperazines; Pyrimidines; Triazoles	2009
Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]. Current opinion in HIV and AIDS, 2009, Volume: 4, Issue:6 Topics: CCR5 Receptor Antagonists; Cyclohexanes; Enfuvirtide; HIV; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Peptide Fragments; Piperazines; Pyrimidines; Salvage Therapy; Triazoles; Virus Internalization	2009
HIV-1 tropism. Protein & cell, 2010, Volume: 1, Issue:6 Topics: Aminoquinolines; Anti-HIV Agents; Benzimidazoles; Benzylamines; Butylamines; CCR5 Receptor Antagonists; CD4 Antigens; Cyclams; Cyclohexanes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; HIV-1; Humans; Maraviroc; Piperazines; Pyrimidines; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Triazoles; Viral Tropism	2010

Other Studies

19 other study(ies) available for triazoles and vicriviroc

Article	Year
Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Binding, Competitive; CCR5 Receptor Antagonists; Cell Line; Cyclohexanes; Drug Synergism; HeLa Cells; HIV Antibodies; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV-1; Humans; Maraviroc; Membrane Fusion; Piperazines; Pyrimidines; Receptors, CCR5; Reverse Transcriptase Inhibitors; Triazoles	2006
The latest in antiretroviral therapy. Drug news & perspectives, 2006, Volume: 19, Issue:8 Topics: Anti-HIV Agents; Anti-Retroviral Agents; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclohexanes; Darunavir; Drugs, Investigational; HIV Infections; HIV-1; Humans; Maraviroc; Nitriles; Organic Chemicals; Piperazines; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Receptors, Chemokine; Sulfonamides; Treatment Outcome; Triazoles	2006
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands. Virology, 2007, Aug-01, Volume: 364, Issue:2 Topics: Animals; Antibodies, Monoclonal; CCR5 Receptor Antagonists; CD4 Antigens; Chemokines, CC; Cyclohexanes; Gene Dosage; HeLa Cells; HIV-1; Humans; In Vitro Techniques; Ligands; Lymphocytes; Macaca mulatta; Maraviroc; Piperazines; Pyrazoles; Pyrimidines; Receptors, CCR5; Simian Immunodeficiency Virus; Triazoles; Valine	2007
Report from the XVI International HIV Drug Resistance Workshop. AIDS clinical care, 2007, Volume: 19, Issue:8 Topics: Anti-HIV Agents; Cyclohexanes; Drug Resistance, Viral; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; Humans; Lopinavir; Maraviroc; Nitriles; Piperazines; Pyridazines; Pyrimidines; Pyrimidinones; Triazoles	2007
Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:12 Topics: Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bridged-Ring Compounds; Carboxylic Acids; CCR5 Receptor Antagonists; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Inhibitors; Humans; Immunologic Factors; In Vitro Techniques; Isoenzymes; Ketoconazole; Kinetics; Liver; Oxidation-Reduction; Piperazines; Pyrimidines; Recombinant Proteins; Substrate Specificity; Testosterone; Triazoles	2007
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists. Molecular pharmacology, 2008, Volume: 73, Issue:3 Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; Benzoates; Binding Sites; CCR5 Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Maraviroc; Membrane Fusion; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Piperazines; Piperidines; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Spiro Compounds; Static Electricity; Transfection; Triazoles	2008
[CCR5 antagonists: a new class of antiretrovirals]. Medecine et maladies infectieuses, 2008, Volume: 38 Suppl 1 Topics: Benzoates; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Piperazines; Pyrimidines; Spiro Compounds; Triazoles	2008
[New antiretroviral drug classes in HIV therapy]. MMW Fortschritte der Medizin, 2009, Apr-30, Volume: 151, Issue:18 Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Maraviroc; Piperazines; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Succinates; Triazoles; Triterpenes; Viral Load	2009
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. Journal of acquired immune deficiency syndromes (1999), 2010, Volume: 55, Issue:4 Topics: Amides; Amino Acid Sequence; Anti-HIV Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; Evolution, Molecular; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Maraviroc; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Peptide Fragments; Piperazines; Pyrimidines; Quaternary Ammonium Compounds; Receptors, CCR5; Triazoles	2010
Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands. Biochemistry, 2011, Feb-01, Volume: 50, Issue:4 Topics: Antibodies, Monoclonal; Crystallography, X-Ray; Cyclohexanes; Fluorescein; HEK293 Cells; Humans; Immunoblotting; Ligands; Lipid Bilayers; Maraviroc; Niacinamide; Piperazines; Protein Binding; Protein Folding; Protein Stability; Pyrimidines; Receptors, CCR5; Solubility; Thermodynamics; Triazoles	2011
Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4 Topics: Animals; Anti-Retroviral Agents; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Cell Survival; Cyclohexanes; Dogs; Gene Expression Profiling; Maraviroc; Piperazines; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles	2011
Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion. PloS one, 2011, Volume: 6, Issue:5 Topics: CCR5 Receptor Antagonists; Clinical Trials, Phase III as Topic; Cloning, Molecular; Cyclohexanes; Down-Regulation; HIV Envelope Protein gp120; HIV-1; Humans; Maraviroc; Models, Biological; Piperazines; Protein Binding; Pyrimidines; Receptors, CCR5; Reproducibility of Results; Sirolimus; Triazoles; Virus Internalization	2011
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. Journal of virology, 2011, Volume: 85, Issue:16 Topics: Anti-HIV Agents; Antibodies, Monoclonal; CCR5 Receptor Antagonists; CD4-Positive T-Lymphocytes; Cell Line; Cell Membrane; Cyclohexanes; Drug Resistance, Viral; Epitopes; Flow Cytometry; HEK293 Cells; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Maraviroc; Membrane Microdomains; Microscopy, Fluorescence; Piperazines; Pyrimidines; Receptors, CCR5; Triazoles; Viral Fusion Proteins; Virus Internalization	2011
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4 Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Antibodies, Blocking; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Piperazines; Pyrimidines; Receptors, CCR5; Triazoles	2012
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc. Virology, 2012, Jun-05, Volume: 427, Issue:2 Topics: Amino Acid Sequence; CCR5 Receptor Antagonists; Cyclohexanes; Drug Resistance, Viral; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Maraviroc; Models, Molecular; Molecular Sequence Data; Peptide Fragments; Piperazines; Protein Conformation; Pyrimidines; Triazoles	2012
CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer research, 2012, Aug-01, Volume: 72, Issue:15 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CCR5 Receptor Antagonists; Chemokine CCL5; Cyclohexanes; Female; Gene Expression Regulation, Neoplastic; Humans; Maraviroc; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Neoplasms, Basal Cell; Piperazines; Pyrimidines; Receptors, CCR5; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2012
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants. Journal of virology, 2013, Volume: 87, Issue:12 Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; CD4-Positive T-Lymphocytes; Cell Line; Cyclohexanes; Drug Resistance, Viral; env Gene Products, Human Immunodeficiency Virus; GTP-Binding Proteins; HEK293 Cells; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Pertussis Toxin; Piperazines; Pyrimidines; Receptors, CCR5; Transfection; Triazoles	2013
Analysis of primary resistance mutations to HIV-1 entry inhibitors in therapy naive subtype C HIV-1 infected mother-infant pairs from Zambia. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013, Volume: 58, Issue:1 Topics: Adult; Amino Acid Sequence; Cloning, Molecular; Cyclohexanes; Drug Resistance, Viral; env Gene Products, Human Immunodeficiency Virus; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maraviroc; Molecular Sequence Data; Mutation, Missense; Piperazines; Pregnancy; Pyrimidines; Sequence Analysis, DNA; Triazoles; Young Adult; Zambia	2013
Synergistic combinations of the CCR5 inhibitor VCH-286 with other classes of HIV-1 inhibitors. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Anti-HIV Agents; Clinical Trials as Topic; Cyclohexanes; Drug Antagonism; Drug Combinations; Drug Synergism; Gene Expression; HIV-1; Humans; Leukocytes, Mononuclear; Maraviroc; Microbial Sensitivity Tests; Piperazines; Pyrimidines; Receptors, CCR5; Reverse Transcriptase Inhibitors; Spiro Compounds; Triazoles; Tropanes; Virus Replication	2014